January 24, 2023
COST-EFFECTIVENESS OF OMALIZUMAB FOR THE TREATMENT OF SEVERE PEDIATRIC ALLERGIC ASTHM...
Antonio Nieto, María Nieto-Cid, Teresa Garriga-Baraut, et al.
June 28, 2022
A practical toolbox for the effective transition of adolescents and young adults with...
Marta Vazquez-Ortiz, Claudia Gore, Cherry Alviani, et al.
October 29, 2020
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent al...
Antonio Nieto García, Teresa Garriga-Baraut, Ana Maria Plaza, et al.
May 28, 2020
EAACI Guideline on the effective transition of adolescents and young adults with alle...
Graham Roberts, Marta Vazquez-Ortiz, Rebecca Knibb, et al.